Mouse marginal zone B cells harbor specificities similar to human broadly neutralizing HIV antibodies

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 4, 2013, Pages 1422-1427

  Pujanauski, Lindsey M ^a,b   Janoff, Edward N ^a   McCarter, Martin D ^a   Pelanda, Roberta ^a,b   Torres, Raul M ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VRC01 ANTIBODY;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; FOLLICULAR B LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOGLOBULIN HEAVY CHAIN GENE; LYMPHOCYTE SUBPOPULATION; MARGINAL ZONE B LYMPHOCYTE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

AIDS VACCINES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODY SPECIFICITY; B-LYMPHOCYTES; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY;

MURINAE; MUS;

EID: 84872856582     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1213713110     Document Type: Article

References (55)

1. McElrath MJ, Haynes BF (2010) Induction of immunity to human immunodeficiency virus type-1 by vaccination. Immunity 33(4):542-554.
2. Johnston MI, Fauci AS (2007) An HIV vaccine - evolving concepts. N Engl J Med 356 (20):2073-2081.
3. Barouch DH (2008) Challenges in the development of an HIV-1 vaccine. Nature 455(7213):613-619.
4. Tomaras GD, et al. (2008) Initial B-cell responses to transmitted human immunodeficiency virus type 1: Virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J Virol 82(24):12449-12463.
5. Verkoczy L, et al. (2010) Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance. Proc Natl Acad Sci USA 107(1):181-186.
6. Zhu P, et al. (2006) Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441(7095):847-852.
7. Ota T, et al. (2012) Anti-HIV B cell lines as candidate vaccine biosensors. J Immunol 189(10):4816-4824.
8. Li Y, et al. (2007) Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat Med 13(9):1032-1034.
9. Walker LM, et al. (2010) A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1-infected individuals. PLoS Pathog 6(8): e1001028.
10. Mikell I, et al. (2011) Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog 7(1):e1001251.
11. Kwong PD, et al. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393(6686):648-659.
12. Wu X, et al. (2010) Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329(5993):856-861.
13. Scheid JF, et al. (2011) Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333(6049):1633-1637.
14. Zhou T, et al. (2010) Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329(5993):811-817.
15. Swanson CL, Pelanda R, Torres RM (2012) Division of labor during primary humoral immunity. Immunol Res, 10.1007/s12026-012-8372-9.
16. Song H, Cerny J (2003) Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen. J Exp Med 198(12):1923-1935.
17. Phan TG, Gardam S, Basten A, Brink R (2005) Altered migration, recruitment, and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen. J Immunol 174(8):4567-4578.
18. Kruetzmann S, et al. (2003) Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 197(7): 939-945.
19. Weller S, et al. (2004) Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104(12):3647-3654.
20. Zandvoort A, Timens W (2002) The dual function of the splenic marginal zone: Essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin Exp Immunol 130(1):4-11.
21. Baxendale HE, et al. (2000) Immunogenetic analysis of the immune response to pneumococcal polysaccharide. Eur J Immunol 30(4):1214-1223.
22. Zhou J, Lottenbach KR, Barenkamp SJ, Reason DC (2004) Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B. Infect Immun 72(6):3505-3514.
23. Scott MG, Zachau HG, Nahm MH (1992) The human antibody V region repertoire to the type B capsular polysaccharide of Haemophilus influenzae. Int Rev Immunol 9(1): 45-55.
24. Insel RA, Adderson EE, Carroll WL (1992) The repertoire of human antibody to the Haemophilus influenzae type b capsular polysaccharide. Int Rev Immunol 9(1):25-43.
25. Chen X, Martin F, Forbush KA, Perlmutter RM, Kearney JF (1997) Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol 9(1):27-41.
26. Mouquet H, et al. (2010) Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 467(7315):591-595.
27. Haynes BF, Moody MA, Verkoczy L, Kelsoe G, Alam SM (2005) Antibody polyspecificity and neutralization of HIV-1: A hypothesis. Hum Antibodies 14(3-4):59-67.
28. Snapper CM, et al. (1993) Comparative in vitro analysis of proliferation, Ig secretion, and Ig class switching by murine marginal zone and follicular B cells. J Immunol 150(7):2737-2745.
29. Oliver AM, Martin F, Gartland GL, Carter RH, Kearney JF (1997) Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 27(9):2366-2374.
30. Guilbert B, Dighiero G, Avrameas S (1982) Naturally occurring antibodies against nine common antigens in human sera, I: Detection, isolation and characterization. J Immunol 128(6):2779-2787.
31. Haspel MV, et al. (1983) Multiple organ-reactive monoclonal autoantibodies. Nature 304(5921):73-76.
32. Fournier EM, et al. (2012) Dual-reactive B cells are autoreactive and highly enriched in the plasmablast and memory B cell subsets of autoimmune mice. J Exp Med 209(10): 1797-1812.
33. Brochet X, Lefranc MP, Giudicelli V (2008) IMGT/V-QUEST: The highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 36(Web Server issue):W503-W508.
34. de Bono B, Madera M, Chothia C (2004) VH gene segments in the mouse and human genomes. J Mol Biol 342(1):131-143.
35. Ehrenmann F, Giudicelli V, Duroux P, Lefranc MP (2011) IMGT/Collier de Perles: IMGT standardized representation of domains (IG, TR, and IgSF variable and constant domains, MH and MhSF groove domains). Cold Spring Harb Protoc 2011(6):726-736.
36. Wu X, et al.; NISC Comparative Sequencing Program (2011) Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333(6049):1593-1602.
37. Carey JB, Moffatt-Blue CS, Watson LC, Gavin AL, Feeney AJ (2008) Repertoire-based selection into the marginal zone compartment during B cell development. J Exp Med 205(9):2043-2052.
38. Reichard KK, McKenna RW, Kroft SH (2003) Comparative analysis of light chain expression in germinal center cells and mantle cells of reactive lymphoid tissues: A fourcolor flow cytometric study. Am J Clin Pathol 119(1):130-136.
39. Yount WJ, Dorner MM, Kunkel HG, Kabat EA (1968) Studies on human antibodies, VI: Selective variations in subgroup composition and genetic markers. J Exp Med 127(3): 633-646.
40. Heng TS, Painter MW; Immunological Genome Project Consortium (2008) The Immunological Genome Project: Networks of gene expression in immune cells. Nat Immunol 9(10):1091-1094.
41. Dosenovic P, et al. (2012) BLyS-mediated modulation of naive B cell subsets impacts HIV Env-induced antibody responses. J Immunol 188(12):6018-6026.
42. Tian C, et al. (2007) Evidence for preferential Ig gene usage and differential TdT and exonuclease activities in human naïve and memory B cells. Mol Immunol 44(9): 2173-2183.
43. Bahler DW, Pindzola JA, Swerdlow SH (2002) Splenic marginal zone lymphomas appear to originate from different B cell types. Am J Pathol 161(1):81-88.
44. Warsame AA, et al. (2011) Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity. Blood 118(12):3331-3339.
45. Wu YC, et al. (2010) High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood 116(7): 1070-1078.
46. Toellner KM, et al. (2002) Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. J Exp Med 195(3):383-389.
47. Weller S, Reynaud CA, Weill JC (2005) Vaccination against encapsulated bacteria in humans: Paradoxes. Trends Immunol 26(2):85-89.
48. Guinamard R, Okigaki M, Schlessinger J, Ravetch JV (2000) Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 1(1):31-36.
49. Rubtsov AV, et al. (2008) TLR agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses. J Immunol 180(6):3882-3888.
50. Genestier L, et al. (2007) TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol 178(12):7779-7786.
51. Bernasconi NL, Onai N, Lanzavecchia A (2003) A role for Toll-like receptors in acquired immunity: Up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101(11):4500-4504.
52. Agematsu K, et al. (1997) B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol 27(8):2073-2079.
53. Shi Y, Agematsu K, Ochs HD, Sugane K (2003) Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high-affinity IgM. Clin Immunol 108(2):128-137.
54. Bryant VL, et al. (2007) Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: Predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J Immunol 179(12):8180-8190.
55. Capolunghi F, et al. (2008) CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol 180(2):800-808.